Calidi Biotherapeutics CLDI
NYSE CLDI
$0.71 -0.06 (-7.60%)
As of: Oct 22, 2026 · 11:17 AM EDT

Calidi Biotherapeutics (CLDI) Minority Interest (2024 - 2025)

Updated

Calidi Biotherapeutics (CLDI) recorded Minority Interest of $280,000 in Q3 2025, down 42.3% from $485,000 a year earlier and down 10.3% from the prior quarter.

Analysis

Calidi Biotherapeutics (CLDI) Minority Interest (2024 - 2025) Analysis & Trends

At the end of FY2024, Calidi Biotherapeutics reported Minority Interest of $434,000.

  • Per Business Quant, the preceding three quarters came in at $312,000 (Q2 2025), $358,000 (Q1 2025) and $434,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn
10 Calidi Biotherapeutics 1.01 Mn -24.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 280,000.00
Jun 30, 2025 312,000.00
Mar 31, 2025 358,000.00
Dec 31, 2024 434,000.00
Sep 30, 2024 485,000.00
API Access

Calidi Biotherapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=CLDI&period=max&api_key=YOUR_API_KEY